Genprex, Inc. — Form 10-Q
Filed August 14, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Ryan M. Confer, serving as both CEO and CFO, certified the Q2 2026 10-Q (quarter ended June 30, 2026) filed August 14, 2026. The certifications attest that financial statements fairly present the company's condition, disclosure controls are effective, and no material weaknesses in internal control were identified. No specific financial data, transactions, or operational changes are disclosed in these certification exhibits.
Why this rating
Routine Sarbanes-Oxley certifications; dual CEO/CFO role is typical for micro-cap. No operational or financial substance disclosed.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.